.png){kind=icon}
.png){kind=icon}
Return
Swiss S1 Guidelines for the Management of Hidradenitis Suppurativa
.png){kind=icon}
PRE
AI
A
E
C
F
J
P
F
S
S
K
V
R
DOI：10.1159/000550649.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition characterized by painful nodules, abscesses, and sinus tracts, causing significant physical and psychological distress. The profound impact of HS underscores the need for comprehensive management strategies to enhance patient outcomes and quality of life. This S1 guideline, developed by the Swiss HS Foundation, provides evidence-based recommendations for systemic and surgical treatments in HS, emphasizing the importance of standardized care practices. It incorporates insights and an informal expert consensus of Swiss dermatologists and dermatosurgeons. The guideline addresses conventional therapies, such as antibiotics and retinoids, as well as emerging biological treatments and surgical interventions, offering a holistic approach to managing this challenging disease.
Keywords:
Hidradenitis suppurativa
Acne inversa
Guideline
Swiss S1 guideline
Dermatology
Treatment pathway
Biologicals
Journal
D
IF:
2.7
Papers:
5.0K
Citations:
6.2K
Organization
Cited Papers